Dosimetric benefit and clinical feasibility of deep inspiration breath-hold and volumetric modulated arc therapy-based postmastectomy radiotherapy for left-sided breast cancer
To evaluate the dosimetric benefits and clinical feasibility of deep inspiratory breath-hold (DIBH) combined with volumetric modulated arc therapy (VMAT) in left-sided postmastectomy radiotherapy (PMRT). Eligible patients with left-sided breast cancer undergoing DIBH-based PMRT were prospectively included. Chest wall, supra/infraclavicular fossa, and/or internal mammary node irradiation (IMNI) were planned with a prescription dose of 43.5 Gy in 15 fractions. VMAT plans were designed on free breathing (FB)-and DIBH-CT to compare dosimetric parameters in heart, left anterior descending artery (LAD) and lung. Cone-beam computed tomography (CBCT) was performed before and after treatment to evaluate inter- and intra-fractional setup errors. Heart position and dose variations during treatment were estimated by fusing CBCT with DIBH-CT scans.Twenty patients were included with 10 receiving IMNI. In total, 193 pre-treatment and 39 pairs pre- and post-treatment CBCT scans were analyzed. The D<sub>mean</sub>, D<sub>max</sub>, and V<sub>5-40</sub> of the heart, LAD, and left lung were significantly lower in DIBH than FB (p < 0.05 for all), except for V5 of LAD (p = 0.167). The cardiopulmonary dosimetric benefits were maintained regardless of IMNI. The inter- and intra-fractional setup errors were < 0.3 cm; and the overall estimated PTV margins were < 1.0 cm. During treatment, the mean dice similarity coefficient of heart position and the mean ratio of heart D<sub>mean</sub> between CBCT and DIBH-CT plans was 0.95 (0.88-1.00) and 100% (70.6-119.5%), respectively. DIBH-VMAT could effectively reduce the cardiopulmonary doses with acceptable reproducibility and stability in left-sided PMRT regardless of IMNI.
Authors
- Jing Hao (ORCID: https://orcid.org/0000-0002-8512-1826)
- Siye Chen (ORCID: https://orcid.org/0009-0002-9672-307X)
- Ningning Lu
- Yueping Liu (ORCID: https://orcid.org/0000-0002-4582-114X)
- Ye‐Xiong Li (ORCID: https://orcid.org/0000-0003-0985-235X)
- Shulian Wang (ORCID: https://orcid.org/0000-0001-7322-9621)
- Yu Tang (ORCID: https://orcid.org/0000-0002-9221-6591)
- Yuan Tang
- Shi-Rui Qin
- Bo Chen (ORCID: https://orcid.org/0000-0002-2216-2794)
- Wen‐Wen Zhang (ORCID: https://orcid.org/0000-0002-7620-5614)
- Shijia Wang (ORCID: https://orcid.org/0000-0002-2241-4808)
- Yirui Zhai
- Hui Fang (ORCID: https://orcid.org/0000-0003-3509-1486)
- Shunan Qi
- Yong-Wen Song
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- National Cancer Center (US)
Publication Details
- Journal
- Scientific Reports
- Published
- 2024-10-20
- DOI
- https://doi.org/10.1038/s41598-024-75560-5
- Citations
- 5
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.43